2017

Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of IND for Micro-Dystrophin Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy

November 6, 2017  /  Comments Off on Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of IND for Micro-Dystrophin Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy

Sarepta Therapeutics and Nationwide Children’s Hospital Announce U.S. Food and Drug Administration (FDA) Clearance of the IND Application for the GALGT2 Gene Therapy Program

November 4, 2017  /  Comments Off on Sarepta Therapeutics and Nationwide Children’s Hospital Announce U.S. Food and Drug Administration (FDA) Clearance of the IND Application for the GALGT2 Gene Therapy Program

Duchenne Family Assistance Program

October 18, 2017  /  Comments Off on Duchenne Family Assistance Program

Duchenne Family Assistance Program

September 1, 2017  /  Comments Off on Duchenne Family Assistance Program

Jammin’ for Joseph 2017

February 6, 2017  /  Comments Off on Jammin’ for Joseph 2017

Partners